Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Eli Lilly and Company(LLY) | 25,665 | 23,415 | -2,250 | $19.97M | $21.20M | 8.62% | +$1.23M |
| LENZ Therapeutics, Inc.(LENZ) | 1,068,675 | 1,084,404 | +15,729 | $23.86M | $18.75M | 7.62% | -$5.11M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 0 | 800,887 | +800,887 | $0 | $14.10M | 5.73% | +$14.10M |
| UnitedHealth Group Incorporated(UNH) | 23,175 | 26,675 | +3,500 | $11.46M | $13.58M | 5.52% | +$2.12M |
| Merck & Co., Inc.(MRK) | 86,500 | 86,500 | 0 | $11.41M | $10.71M | 4.35% | -$705.0K |
| Johnson & Johnson(JNJ) | 47,850 | 56,850 | +9,000 | $7.57M | $8.31M | 3.38% | +$739.8K |
| AbbVie Inc.(ABBV) | 35,200 | 44,950 | +9,750 | $6.41M | $7.71M | 3.13% | +$1.30M |
| Abbott Labs | 70,248 | 66,248 | -4,000 | $7.98M | $6.88M | 2.80% | -$1.10M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 7,075 | 6,040 | -1,035 | $6.81M | $6.35M | 2.58% | -$461.4K |
| Thermo Fisher Scientific Inc.(TMO) | 10,015 | 10,515 | +500 | $5.82M | $5.81M | 2.36% | -$6.0K |
| Boston Scientific Corporation(BSX) | 86,476 | 71,476 | -15,000 | $5.92M | $5.50M | 2.24% | -$418.4K |
| Mineralys Therapeutics, Inc.(MLYS) | 552,256 | 438,748 | -113,508 | $7.13M | $5.13M | 2.09% | -$2.00M |
| Pfizer Inc.(PFE) | 189,400 | 181,400 | -8,000 | $5.26M | $5.08M | 2.06% | -$180.3K |
| Gilead Sciences, Inc.(GILD) | 38,705 | 68,825 | +30,120 | $2.84M | $4.72M | 1.92% | +$1.89M |
| Medtronic plcSHS(MDT) | 38,051 | 59,551 | +21,500 | $3.32M | $4.69M | 1.90% | +$1.37M |
| Amgen Inc.(AMGN) | 16,085 | 14,700 | -1,385 | $4.57M | $4.59M | 1.87% | +$19.7K |
| Danaher Corporation(DHR) | 17,725 | 17,725 | 0 | $4.43M | $4.43M | 1.80% | +$2.3K |
| Stryker Corporation(SYK) | 6,600 | 12,850 | +6,250 | $2.36M | $4.37M | 1.78% | +$2.01M |
| Vertex Pharmaceuticals Incorporated(VRTX) | 7,210 | 8,650 | +1,440 | $3.01M | $4.05M | 1.65% | +$1.04M |
| DexCom, Inc.(DXCM) | 32,400 | 32,150 | -250 | $4.49M | $3.65M | 1.48% | -$848.7K |
| BioMarin Pharmaceutical Inc.(BMRN) | 51,640 | 41,260 | -10,380 | $4.51M | $3.40M | 1.38% | -$1.11M |
| IQVIA Holdings Inc.(IQV) | 14,100 | 15,600 | +1,500 | $3.57M | $3.30M | 1.34% | -$267.3K |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 18,460 | 12,480 | -5,980 | $2.76M | $3.03M | 1.23% | +$273.8K |
| Zimmer Biomet Holdings, Inc.(ZBH) | 29,750 | 26,650 | -3,100 | $3.93M | $2.89M | 1.18% | -$1.03M |
| argenx SEADR(ARGX) | 9,307 | 6,522 | -2,785 | $3.66M | $2.80M | 1.14% | -$859.6K |
| Boundless Bio, Inc.(BOLD) | 855,875 | 682,274 | -173,601 | $12.20M | $2.64M | 1.07% | -$9.56M |
| Moderna, Inc.(MRNA) | 14,740 | 22,110 | +7,370 | $1.57M | $2.63M | 1.07% | +$1.05M |
| Vaxcyte, Inc.(PCVX) | 8,500 | 33,730 | +25,230 | $580.6K | $2.55M | 1.04% | +$1.97M |
| ICON Public Limited CompanySHS(ICLR) | 7,943 | 8,028 | +85 | $2.67M | $2.52M | 1.02% | -$151.9K |
| Elevance Health, Inc.(ELV) | 3,500 | 4,500 | +1,000 | $1.81M | $2.44M | 0.99% | +$623.5K |
| Intuitive Surgical, Inc.(ISRG) | 6,100 | 5,400 | -700 | $2.43M | $2.40M | 0.98% | -$32.3K |
| CVS Health Corporation(CVS) | 0 | 39,000 | +39,000 | $0 | $2.30M | 0.94% | +$2.30M |
| BioNTech SEADR(BNTX) | 3,525 | 27,265 | +23,740 | $325.2K | $2.19M | 0.89% | +$1.87M |
| Amicus Therapeutics COM | 221,044 | 216,844 | -4,200 | $2.60M | $2.15M | 0.87% | -$452.8K |
| Sarepta Therapeutics, Inc.(SRPT) | 17,291 | 13,496 | -3,795 | $2.24M | $2.13M | 0.87% | -$106.1K |
| GoodRx Holdings, Inc.(GDRX) | 321,000 | 265,000 | -56,000 | $2.28M | $2.07M | 0.84% | -$212.1K |
| ARS Pharmaceuticals, Inc.(SPRY) | 204,437 | 236,937 | +32,500 | $2.09M | $2.02M | 0.82% | -$73.0K |
| Progyny Inc | 76,000 | 70,000 | -6,000 | $2.90M | $2.00M | 0.81% | -$896.7K |
| Cytokinetics, Incorporated(CYTK) | 42,583 | 36,883 | -5,700 | $2.99M | $2.00M | 0.81% | -$987.2K |
| Inari Med Inc | 52,500 | 40,500 | -12,000 | $2.52M | $1.95M | 0.79% | -$568.9K |
| Option Care Health, Inc.(OPCH) | 64,000 | 65,000 | +1,000 | $2.15M | $1.80M | 0.73% | -$346.1K |
| Humana Inc.(HUM) | 4,751 | 4,751 | 0 | $1.65M | $1.78M | 0.72% | +$127.9K |
| AstraZeneca PLCADR(AZN) | 24,430 | 21,650 | -2,780 | $1.66M | $1.69M | 0.69% | +$33.4K |
| Stevanato Group Spa ORD SHS | 0 | 89,000 | +89,000 | $0 | $1.63M | 0.66% | +$1.63M |
| Evolent Health, Inc.CL A(EVH) | 0 | 84,000 | +84,000 | $0 | $1.61M | 0.65% | +$1.61M |
| Insulet Corporation(PODD) | 18,100 | 7,350 | -10,750 | $3.10M | $1.48M | 0.60% | -$1.62M |
| Edwards Lifescience | 15,650 | 15,650 | 0 | $1.50M | $1.45M | 0.59% | -$49.9K |
| Iteos Therapeutics | 133,966 | 96,966 | -37,000 | $1.83M | $1.44M | 0.58% | -$388.3K |
| Biogen Inc.(BIIB) | 6,967 | 6,137 | -830 | $1.50M | $1.42M | 0.58% | -$79.6K |
| Turnstone Biologics | 517,648 | 517,648 | 0 | $1.36M | $1.36M | 0.55% | $0 |
| Olema Pharmaceuticals, Inc.(OLMA) | 139,980 | 118,480 | -21,500 | $1.58M | $1.28M | 0.52% | -$302.6K |
| Bristol-Myers Squibb Company(BMY) | 0 | 30,000 | +30,000 | $0 | $1.25M | 0.51% | +$1.25M |
| Arcus Biosciences, Inc.COM USD(RCUS) | 93,635 | 78,385 | -15,250 | $1.77M | $1.19M | 0.49% | -$574.0K |
| The Cigna Group(CI) | 0 | 3,500 | +3,500 | $0 | $1.16M | 0.47% | +$1.16M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 46,295 | 21,428 | -24,867 | $2.33M | $942.2K | 0.38% | -$1.38M |
| Becton, Dickinson and Company(BDX) | 0 | 4,000 | +4,000 | $0 | $934.8K | 0.38% | +$934.8K |
| Arvinas, Inc.(ARVN) | 48,780 | 34,830 | -13,950 | $2.01M | $927.2K | 0.38% | -$1.09M |
| Cogent Biosciences, Inc.(COGT) | 263,700 | 85,600 | -178,100 | $1.77M | $721.6K | 0.29% | -$1.05M |
| ADC Therapeutics SASHS(ADCT) | 0 | 228,102 | +228,102 | $0 | $720.8K | 0.29% | +$720.8K |
| Insmed Incorporated(INSM) | 16,421 | 9,821 | -6,600 | $445.5K | $658.0K | 0.27% | +$212.5K |
| Illumina, Inc.(ILMN) | 6,280 | 5,810 | -470 | $862.4K | $606.4K | 0.25% | -$255.9K |
| United Therapeutics Corporation(UTHR) | 2,595 | 1,820 | -775 | $596.1K | $579.8K | 0.24% | -$16.4K |
| Neurocrine Biosciences, Inc.(NBIX) | 4,195 | 3,935 | -260 | $578.6K | $541.7K | 0.22% | -$36.8K |
| Incyte Corporation(INCY) | 9,405 | 8,905 | -500 | $535.8K | $539.8K | 0.22% | +$4.0K |
| Structure TherapeuADR | 5,964 | 13,365 | +7,401 | $255.6K | $524.8K | 0.21% | +$269.2K |
| Roivant Sciences Ltd.SHS(ROIV) | 49,457 | 45,957 | -3,500 | $521.3K | $485.8K | 0.20% | -$35.5K |
| Ionis Pharmaceuticals, Inc.(IONS) | 10,100 | 9,660 | -440 | $437.8K | $460.4K | 0.19% | +$22.6K |
| Medpace Holdings, Inc.(MEDP) | 1,291 | 1,106 | -185 | $521.8K | $455.5K | 0.19% | -$66.3K |
| Intra Cellular Thera | 7,080 | 6,530 | -550 | $489.9K | $447.2K | 0.18% | -$42.7K |
| Royalty Pharma plcCL A(RPRX) | 19,420 | 16,650 | -2,770 | $589.8K | $439.1K | 0.18% | -$150.7K |
| Blueprint Medicines | 4,410 | 3,850 | -560 | $418.3K | $415.0K | 0.17% | -$3.4K |
| Alkermes plcSHS(ALKS) | 14,230 | 16,730 | +2,500 | $385.2K | $403.2K | 0.16% | +$18.0K |
| Apellis Pharmaceutic COM | 9,670 | 10,460 | +790 | $568.4K | $401.2K | 0.16% | -$167.2K |
| BridgeBio Pharma, Inc.(BBIO) | 16,105 | 15,535 | -570 | $498.0K | $393.5K | 0.16% | -$104.5K |
| Ascendis Pharma A/SADR(ASND) | 4,011 | 2,666 | -1,345 | $606.3K | $363.6K | 0.15% | -$242.8K |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 3,894 | 3,334 | -560 | $468.9K | $355.8K | 0.14% | -$113.1K |
| SanofiADR(SNY) | 12,670 | 7,330 | -5,340 | $615.8K | $355.7K | 0.14% | -$260.1K |
| BeOne Medicines AGADR(ONC) | 3,692 | 2,447 | -1,245 | $577.4K | $349.1K | 0.14% | -$228.3K |
| Dr. Reddy's Laboratories LimitedADR(RDY) | 5,500 | 4,500 | -1,000 | $403.4K | $342.9K | 0.14% | -$60.6K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 1,131 | 1,065 | -66 | $302.0K | $298.4K | 0.12% | -$3.7K |
| Vera Therapeutics, Inc.CL A(VERA) | 44,901 | 7,718 | -37,183 | $1.94M | $279.2K | 0.11% | -$1.66M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 14,810 | 12,530 | -2,280 | $399.0K | $269.8K | 0.11% | -$129.2K |
| Crinetics Pharmace | 0 | 5,800 | +5,800 | $0 | $259.8K | 0.11% | +$259.8K |
| Exelixis, Inc.(EXEL) | 13,140 | 11,460 | -1,680 | $311.8K | $257.5K | 0.10% | -$54.3K |
| Revolution Medicines, Inc.(RVMD) | 12,910 | 6,600 | -6,310 | $416.1K | $256.1K | 0.10% | -$159.9K |
| Viatris Inc.(VTRS) | 0 | 22,500 | +22,500 | $0 | $239.2K | 0.10% | +$239.2K |
| Halozyme Therapeutics, Inc.(HALO) | 5,680 | 3,815 | -1,865 | $231.1K | $199.8K | 0.08% | -$31.3K |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 7,682 | 7,522 | -160 | $219.7K | $195.5K | 0.08% | -$24.2K |
| Summit Therapeutics Inc.(SMMT) | 315,000 | 25,000 | -290,000 | $1.30M | $195.0K | 0.08% | -$1.11M |
| Biohaven Ltd.(BHVN) | 0 | 3,900 | +3,900 | $0 | $135.4K | 0.06% | +$135.4K |
| PTC Therapeutics, Inc.(PTCT) | 0 | 4,300 | +4,300 | $0 | $131.5K | 0.05% | +$131.5K |
| Scholar Rock Holding Corporation(SRRK) | 15,400 | 15,030 | -370 | $273.5K | $125.2K | 0.05% | -$148.3K |
| Perspective Therapeutics, Inc.(CATX) | 0 | 11,000 | +11,000 | $0 | $109.7K | 0.04% | +$109.7K |
| Legend Biotech CorporationADR(LEGN) | 3,000 | 2,000 | -1,000 | $168.3K | $88.6K | 0.04% | -$79.7K |
| Kyverna Therapeutics, Inc.(KYTX) | 7,000 | 7,000 | 0 | $173.9K | $52.5K | 0.02% | -$121.4K |
| Zai Lab LimitedADR(ZLAB) | 2,000 | 2,000 | 0 | $32.0K | $34.7K | 0.01% | +$2.6K |
| GRAIL, Inc.(GRAL) | 0 | 240 | +240 | $0 | $3.7K | 0.00% | +$3.7K |
| Acelyrin Inc | 244,000 | 0 | -244,000 | $1.65M | $0 | — | -$1.65M |
| Alphatec Holdings, Inc.(ATEC) | 136,000 | 0 | -136,000 | $1.88M | $0 | — | -$1.88M |
| Altimmune, Inc.(ALT) | 92,240 | 0 | -92,240 | $939.0K | $0 | — | -$939.0K |